Conavi Medical Corp (CNVI.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in thousands)
| 09-2025 | 09-2024 | |
| Sales | 9,122 | 2,161 |
| Cost of Goods | 1,495 | 2,108 |
| Gross Profit | 7,627 | 53 |
| Operating Expenses | 22,479 | 26,286 |
| Operating Income | -14,852 | -26,233 |
| Interest Expense | 11,686 | 8,016 |
| Other Income | 6,022 | -9,366 |
| Pre-tax Income | -20,516 | -43,615 |
| Net Income Continuous | -20,516 | -43,615 |
| Net Income | $-20,516 | $-43,615 |
| EPS Basic Total Ops | -0.36 | -0.99 |
| EPS Basic Continuous Ops | -0.36 | N/A |
| EPS Diluted Total Ops | -0.36 | -0.99 |
| EPS Diluted Continuous Ops | -0.36 | N/A |
| EBITDA(a) | $-8,017 | $-34,612 |